2-(4-dibenzofuran-4-ylphenyl)-4-(3,5-dipyridin-2-ylphenyl)-5,5-dimethylindeno[1,2-d]pyrimidine
C47H32N4O — CID 118100071
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-dibenzofuran-4-ylphenyl)-4-(3,5-dipyridin-2-ylphenyl)-5,5-dimethylindeno[1,2-d]pyrimidine
2-(4-dibenzofuran-4-ylphenyl)-4-(3,5-dipyridin-2-ylphenyl)-5,5-dimethylindeno[1,2-d]pyrimidine (PubChem CID 118100071) has the molecular formula C47H32N4O and a molecular weight of 668.80 g/mol. Its IUPAC name is 2-(4-dibenzofuran-4-ylphenyl)-4-(3,5-dipyridin-2-ylphenyl)-5,5-dimethylindeno[1,2-d]pyrimidine.
Molecular Properties
| Compound Name | 2-(4-dibenzofuran-4-ylphenyl)-4-(3,5-dipyridin-2-ylphenyl)-5,5-dimethylindeno[1,2-d]pyrimidine |
|---|---|
| PubChem CID | 118100071 |
| Molecular Formula | C47H32N4O |
| Molecular Weight | 668.80 g/mol |
| Exact Mass | 668.26 |
| IUPAC Name | 2-(4-dibenzofuran-4-ylphenyl)-4-(3,5-dipyridin-2-ylphenyl)-5,5-dimethylindeno[1,2-d]pyrimidine |
| SMILES | CC1(C)c2ccccc2-c2nc(-c3ccc(-c4cccc5c4oc4ccccc45)cc3)nc(-c3cc(-c4ccccn4)cc(-c4ccccn4)c3)c21 |
| InChI | InChI=1S/C47H32N4O/c1-47(2)38-16-5-3-13-37(38)44-42(47)43(33-27-31(39-17-7-9-24-48-39)26-32(28-33)40-18-8-10-25-49-40)50-46(51-44)30-22-20-29(21-23-30)34-14-11-15-36-35-12-4-6-19-41(35)52-45(34)36/h3-28H,1-2H3 |
| InChIKey | PAWZNAIXHYLAAQ-UHFFFAOYSA-N |
| XLogP | 11.81 |
| TPSA | 64.70 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 52 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 668.80 |
| LogP ≤ 5 | 11.81 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118100071 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.